Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:41 AM
Ignite Modification Date:
2025-12-25 @ 1:41 AM
NCT ID:
NCT04005794
Eligibility Criteria:
1. Inclusion and Exclusion Criteria for Individuals with Schizophrenia:
Inclusion criteria for schizophrenia group:
* Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) Axis 1 Diagnosis of schizophrenia
* Wechsler Abbreviated Scale of Intelligence (WASI) intelligence quotient (IQ) \> 85
* Currently taking antipsychotic medication
* No change in current psychotropic medications or housing within the past 30 days. Those patients whose medication or housing situation has changed within a month, we will wait list them until their situation stabilizes.
Exclusion criteria for schizophrenia group:
* Diagnostic and Statistical Manual of Mental Disorders-5 (DSM 5) Axis 1 diagnosis other than schizophrenia
* Diagnosed organic brain disease, brain lesions, history of head traumas, neurological disorders or other conditions that involve the degeneration of the central nervous system (e.g. multiple sclerosis)
* Substance/alcohol dependence during the past 1 year
* Tardive dyskinesia
2. Inclusion and Exclusion Criteria for Healthy Control Participants:
* Wechsler Abbreviated Scale of Intelligence (WAIS) IQ \> 85
* No Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) Axis 1 diagnosis of psychotic disorders in themselves or their families (e.g. schizophrenia, bipolar disorder).
* No antipsychotic medications
* No diagnosed organic brain disease, brain lesions, history of head traumas, neurological disorders or other conditions that involve the degeneration of the central nervous system (e.g. multiple sclerosis)
* No substance/alcohol dependence during the past 1 year
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT04005794
Study Brief:
Protocol Section:
NCT04005794